Summary
Website: Alcon
Headquarters: Hünenberg, Switzerland
Ticker Symbol: AKR (Frankfurt Stock Exchange) ACL (New York Stock Exchange)
SEC Link: Alcon
Subsidiaries:
Alcon Laboratories
Top 50 Pharma ranking*: 38
*Ranking based on reported global pharma sales for year ending December 2010.
Sales revenue (USD billions) [% change from 2009]: $3.1 [14.5%]
R&D spend (USD millions): $747
Top-selling drugs (USD billions): Glaucoma products [1.3]
Partnering activity
View partnering activity: 2011,2010,2009,2008,2007,2006,2005
Full details on each deal can be found at CurrentAgreements (subscription required)
M&A activity
View M&A activity: 2011,2010,2009,2008,2007,2006,2005
Full details on each deal can be found at CurrentAgreements (subscription required)
Available reports from Current Partnering:
Partnering Agreements with Alcon
Partnering Agreements with Big Pharma, 3rd edition
Available resources providing deal coverage for Alcon:
Current Agreements (subscription required)
